New Funding for Diabetes & Cardiovascular Disease on Offer Through the TTRA Initiative

10/20/21 • 68 min

The Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease, supported by the Medical Research Future Fund, is providing a new integrated research program to improve the prevention, diagnosis, treatment and management of diabetes and cardiovascular disease (D&CVD) in Australia. The TTRA is calling for Expressions of Interest (EOI) for the second round of the Research Projects opportunity to fund eligible organisations in developing innovative digital health solutions, medical devices, therapeutics and behavioural interventions for D&CVD. This Information Session webinar provides valuable information about the funding application process, priority research areas & includes a Question & Answer segment. Applications close 25 November 2021 (deadline extended)!

Hear from MTPConnect’s team:

Managing Director & CEO - Dr Dan Grant, Senior Director TTRA Program - Lauren Kelly, Director TTRA Program - Dr Mana Liao and Project Manager TTRA Program - Dr Erin McAllum.

You will also hear from our TTRA program partners who will provide mentoring and commercialisation advice to applicants and those receiving funding:

ANDHealth's Chief Product Officer & Co-Founder - Grace Lethlean, MDPP's National Program Manager - Olivia White and UniQuest's Project Manager, TTRA Program - Dr Leigh Ford.

Hear from MTPConnect’s team:

Managing Director & CEO - Dr Dan Grant, Senior Director TTRA Program - Lauren Kelly, Director TTRA Program - Dr Mana Liao and Project Manager TTRA Program - Dr Erin McAllum.

You will also hear from our TTRA program partners who will provide mentoring and commercialisation advice to applicants and those receiving funding:

ANDHealth's Chief Product Officer & Co-Founder - Grace Lethlean, MDPP's National Program Manager - Olivia White and UniQuest's Project Manager, TTRA Program - Dr Leigh Ford.

Previous Episode

Trials & Tribulations - Developing the World-First Oxford AstraZeneca COVID-19 Vaccine

Dr Maheshi Ramasamy is a Principal Investigator at the Oxford Vaccine Group where she leads on adult clinical vaccine trials including the Oxford AstraZeneca COVID-19 vaccine trials. Dr Ramasamy joins the podcast from the UK to take us through the challenges of developing a successful international clinical trial against the clock during a fast-moving pandemic, her experiences as a clinician scientist working on the frontline in UK COVID hospital wards and the impact of securing approval for the vaccine. MTPConnect co-hosts MD and CEO Dr Dan Grant and COO Stuart Dignam chat to Dr Ramasamy about concerns over vaccine safety, rare adverse events, vaccine hesitancy and fake news. Dr Ramasamy, an Australian Sri Lankan, shares her motivations and research interests. She also explains how her international career pathway – including working at Australia's Ballarat Base Hospital - helped her to pursue this challenge of a lifetime. Dr Ramasamy is also a Consultant Physician at Oxford University Hospitals NHS Foundation Trust, the Deputy Director of the Graduate Entry Medicine course at Oxford and the Florey Lecturer at Oxford’s Magdalen College.

Next Episode

Visionary Telehealth Start-Up Coviu Builds a Platform for Global Growth

We catch up with medtech start-up Coviu, the company behind a game-changing video telehealth software that is now being used by 65,000+ health professionals in Australia.

Coviu recently took out two awards at the Australian Technologies Competition (ATC), an accelerator program that MTPConnect supports in partnership with the Australian Government’s Department of Industry, Science, Energy and Resources.

Coviu Global’s Director & CEO Dr Silvia Pfeiffer, a start-up veteran, shares the company's journey starting with the spin out from Data61/CSIRO, scaling up during the COVID-19 pandemic to providing 5.5 million telehealth consultations to date. Dr Pfeiffer also outlines the benefits of participating in an accelerator program for start- ups who are commercialising and growing rapidly. An episode not to be missed!